Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Viridian Therapeutics
VRDN
$2.67B
| $20.8M | ﹤0.01% |
710,985
+111,219
| +19% | +$2.56M |
|
1752
Energy Recovery
ERII
$443M
| $20.8M | ﹤0.01% |
1,012,923
+35,506
| +4% | +$777K |
|
1753
Abercrombie & Fitch
ANF
$5B
| $20.7M | ﹤0.01% |
903,876
+16,073
| +2% | +$317K |
|
1754
QuantumScape Corp
QS
$3.74B
| $20.7M | ﹤0.01% |
3,646,075
+255,729
| +8% | +$1.89M |
|
|
EVA
1755
DELISTED
Enviva Inc.
EVA
| $20.6M | ﹤0.01% |
388,310
+22,866
| +6% | +$1.31M |
|
1756
US Physical Therapy
USPH
$1.22B
| $20.6M | ﹤0.01% |
253,802
-284
| -0.1% | -$23.8K |
|
1757
Tennant Co
TNC
$1.26B
| $20.6M | ﹤0.01% |
333,840
+11,038
| +3% | +$675K |
|
1758
DoubleVerify
DV
$2.03B
| $20.5M | ﹤0.01% |
933,758
+172,597
| +23% | +$4.5M |
|
|
PMT
1759
PennyMac Mortgage Investment
PMT
$842M
| $20.4M | ﹤0.01% |
1,649,422
+2,679
| +0.2% | +$36.4K |
|
1760
Construction Partners
ROAD
$6.77B
| $20.4M | ﹤0.01% |
765,536
+24,551
| +3% | +$704K |
|
|
NXGN
1761
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $20.4M | ﹤0.01% |
1,086,744
+38,780
| +4% | +$747K |
|
1762
Heritage Financial
HFWA
$1.21B
| $20.4M | ﹤0.01% |
664,419
+23,865
| +4% | +$747K |
|
|
BRKL
1763
DELISTED
Brookline Bancorp
BRKL
| $20.3M | ﹤0.01% |
1,434,783
+30,200
| +2% | +$404K |
|
|
SPTN
1764
DELISTED
SpartanNash
SPTN
| $20.3M | ﹤0.01% |
670,423
+18,292
| +3% | +$596K |
|
1765
Amphastar Pharmaceuticals
AMPH
$916M
| $20.2M | ﹤0.01% |
722,281
+14,075
| +2% | +$409K |
|
1766
Kanzhun
BZ
$7.36B
| $20.2M | ﹤0.01% |
994,565
+61,605
| +7% | +$1.01M |
|
1767
RB Global
RBA
$17.5B
| $20.2M | ﹤0.01% |
348,318
+721
| +0.2% | +$42K |
|
1768
Recursion Pharmaceuticals
RXRX
$1.73B
| $20.1M | ﹤0.01% |
2,609,948
+277,865
| +12% | +$2.72M |
|
1769
Clearfield
CLFD
$374M
| $20.1M | ﹤0.01% |
213,490
+7,917
| +4% | +$835K |
|
1770
Ligand Pharmaceuticals
LGND
$6.36B
| $20.1M | ﹤0.01% |
300,670
-164,376
| -35% | -$10.7M |
|
|
HPP
1771
Hudson Pacific Properties
HPP
$779M
| $20.1M | ﹤0.01% |
294,669
+7,897
| +3% | +$586K |
|
1772
The Greenbrier Companies
GBX
$1.46B
| $20M | ﹤0.01% |
597,243
+31,780
| +6% | +$1.06M |
|
1773
Alignment Healthcare
ALHC
$2.98B
| $20M | ﹤0.01% |
1,702,040
+164,986
| +11% | +$2.01M |
|
|
NXRT
1774
NexPoint Residential Trust
NXRT
$652M
| $20M | ﹤0.01% |
459,891
+18,695
| +4% | +$836K |
|
|
RETA
1775
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $20M | ﹤0.01% |
526,116
+22,196
| +4% | +$764K |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.